from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2203/-

LFCtreatmentdescriptionclass of inhibitor

-0.024

Amikacinug/mL Amikacintranslation

0.945

Cap5-10ug/mL Capreomycintranslation

1.125

Rox10-50 ug/mL Roxithromycintranslation

0.420

SM2-5 ug/mL Streptomycintranslation

-0.010

Tet5-10 ug/mL Tetracyclinetranslation

-0.094

Rif0.2-5ug/mL Rifampicintranscription

-0.287

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.017

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.269

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.611

CPZ10-50 ug/mL Chlorpromazinerespiration

0.277

Clofazimine10-13 ug/mL Clofaziminerespiration

0.512

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.646

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.656

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.302

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.596

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.154

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.031

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.854

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.550

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.713

KCN5-20 ug/mL Potassium cyaniderespiration

-0.105

NaN30.2-2 mM Sodium aziderespiration

0.788

Nigericin50 uM Nigericinrespiration

-1.343

TRC10-150 ug/mL Triclosanrespiration

-1.024

TRZ10-25 ug/mL Thioridazinerespiration

0.958

Valinomycin0.5-10 uM Valinomycinrespiration

0.962

ZnSO42 mM ZnSO4respiration

1.352

menadione6-10 ug/mL Menadionerespiration

0.498

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.526

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.107

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.739

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.799

NRP_1Non-replicating persistence stage 1dosRassociated

0.615

Amp0.2mg/mL AmpicillincellWall

0.526

Cephalexin20-100 ug/mL CephalexincellWall

0.790

Cerulenin0.32-5 ug/mL CerulenincellWall

0.395

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.393

EMB10-20 ug/mL EthambutolcellWall

0.585

Eta12-40 ug/mL EthionamidecellWall

0.494

INH0.2-0.4 ug/mL IsoniazidcellWall

0.740

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.514

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.740

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.293

BZA0.12 mg/mL BenzamidearomaticAmides

-0.965

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.833

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.833

H2O24 mM hydrogen peroxideDNAdamaging

0.494

Levo10 ug/mL LevofloxacinDNAdamaging

-0.148

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.383

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.278

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.013

UVUV-irradiationDNAdamaging

0.969

ARP41-4 ug/mL Antitubercular compound ARP4?

0.399

Antimycin12.5-50 ug/mL Antimycin A?

0.816

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.152

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.153

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.664

PA8240.2-2 ug/mL PA-824?

-1.272

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.073

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.156

Verapamil50 uM Verapamil?

1.121

mercaptoethanol2 mM 2-Mercaptoethanol?

0.827

methoxatin10-20 ug/mL Methoxatin?